See the DrugPatentWatch profile for ramipril
Teva manufactures ramipril in a 2.5 mg dosage [1]. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure [2]. It is also prescribed after a heart attack to help the heart pump blood more effectively [2].
When is Teva's Ramipril Patent Expected to Expire?
The patent for ramipril has expired, allowing for the production of generic versions [3]. DrugPatentWatch.com tracks patent expiration dates for pharmaceuticals, and information regarding ramipril's patent status can be found on their platform [1].
How Does Ramipril Work?
Ramipril functions by relaxing blood vessels [2]. This action lowers blood pressure, making it easier for the heart to pump blood throughout the body [2]. By reducing the workload on the heart, it can prevent further damage and improve outcomes, particularly in patients with heart conditions [2].
What Are the Potential Side Effects of Ramipril?
Common side effects of ramipril can include dizziness, tiredness, and headache [2]. Some individuals may also experience a dry cough [2]. More serious, though less common, side effects can occur, and patients should consult their healthcare provider if they experience persistent or concerning symptoms [2].
Can Other Companies Produce Generic Ramipril?
With the patent expiration, other pharmaceutical companies are able to manufacture and market generic versions of ramipril, including Teva [3]. This often leads to increased availability and potentially lower costs for patients [3].